Authors
Gantsgorn E. V.
PhD, Assistant, Chair for Pharmacology and Clinical Pharmacology1
Alekseev A. N.
Lieutenant of medical service2
1 - Rostov State Medical University, Rostov-on-Don, Russia
2 - Military unit 55796, Morozovsk, Russia
Corresponding Author
Gantsgorn Elena Vladimirovna; e-mail: gantsgorn@inbox.ru
Conflict of interest
None declared.
Funding
The study had no sponsorship.
Abstract
A description of the clinical case is given in a 46-year-old patient with diabetes mellitus type 2 and a number of associated diseases. The stages of the performed diagnostic search are presented with the verification of the clinical diagnosis and the tactics of the prescribed pharmacotherapy.
Key words
diabetes mellitus type 2, polymorbidity, polypragmasy
DOI
References
1. Madyanov, I.V., Dolgova M.V., Domanova T.G. Problema «trekh p» – polimorbidnosti, polipragmazii i priverzhennosti pacientov k lecheniyu – pri saharnom diabete 2-go tipa [The problem of «three p» – polymorbidity, polypragmasy and adherence of patients to treatment – with type 2 diabetes mellitus]. Zdravoohranenie Chuvashii [Health care of Chuvashia] 2014; (1): 76-78. (In Russ.)
2. Sychev, D.A., Otdelenov V.A., Krasnova N.M., Il'ina E.S. Polipragmaziya: vzglyad klinicheskogo farmakologa [Polypragmasy: a view of a clinical pharmacologist]. Terapevticheskij arhiv [Therapeutic Archive] 2016; 88 (12): 94-102. (In Russ.)
3. Tereshchenko, I.V. Grachyova Yu.A., Kayushev P.E. Vynuzhdennaya postoyannaya polipragmaziya i risk pobochnyh reakcij u bol'nyh saharnym diabetom tipa 2 [Forced constant polypragmasy and risk of adverse reactions in patients with type 2 diabetes mellitus]. Biomedicina [Biomedicine] 2010; (3): 152-154. (In Russ.)
4. Foneski, V. Metabolicheskij sindrom [Metabolic syndrome]. Moscow: Praktika, 2011. (In Russ.)
5. Guthrie, B., Makubate B., Hernandez-Santiag V., Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010 BMC Med. 2015; (13): 74.
6. Walckier, D. Heyden J. Van der, Tafforeau J. Factors associated with excessive polypharmacy in older people. Arch Public Health. 2015; 73: 50.
